Chengdu MedArt Medical Scientific Co., Ltd. is a National High-tech Enterprise committed to the development and application of biomedical materials, with a deep background in the absorbable medical device industry. Relying on the biomedical engineering transformation platform of absorbable polyester and modified gelatin materials built by the company, the company has designed and built a complete product line of absorbable internal fixation and repair for neurosurgery, filling a number of domestic gaps, and was the first to complete the medical devices' main document registration of poly L-lactic acid for surgical implantation by NMPA. It aims to develop into a professional and reliable supplier of biomedical materials and regenerative medicine products. "Absorbable Cranial Flap Fixation System", a class III implant medical device independently developed by the company, is the first absorbable medical product approved by the NMPA for internal fixation in neurosurgery in China, and won the 2019 iF Design Award and 2020 Red Dot Product Design Award.
2022/03 The construction of Area D was completed and some departments of the company was relocated
2022/05 The registration of the Absorbable Craniomaxillofacial Fixation System was accepted
2022/07 The company's Absorbable Cranial Flap Fixation System has been granted PCT US invention patent.
2022/11 The company passed the certification of "SRDI" small and medium-sized enterprises in Sichuan Province for the first time
2022/11 MedArt obtained the Class III medical device registration certificate of Polyetheretherketone(PEEK) Cranial Repair Plate
2021/03 MedArt completed the A+ round financing
2021/05 MedArt completed the medical devices' main document filing of poly L-lactic acid material for surgical implantation (Main Document Registration
2021/05 MedArt obtained the registration certificate of "Sterile Medical Ultrasonic Gel"
2021/06 MedArt obtained the first Class III medical device registration certificate of Absorbable Cranial Flap Fixation System in the same kind of products in China
2021/07 The company obtained the production license of Class III medical devices
2021/09 The European invention patent for MedArt Absorbable Cranial Flap Fixation System was applied.
2021/12 MedArt passed the ISO13485:2016 Quality System Certification assessed by SGS
2020/02 MedArt was successfully listed in the "Epidemic Prevention and Control Capability List of Chengdu New Economy Enterprises (the first batch)"
2020/03 The Absorbable Cranial Flap Fixation System of MedArt won the Red Dot Award: Product Design 2020
2020/06 The company's Hand Sanitizer Gel passed FDA certification (FDA202006-001)
2020/12 MedArt was identified as the Chengdu New Materials Enterprises
2019/01 MedArt was selected as the most potential enterprise of Sichuan Strategic Emerging Industry Promotion Agency
2019/01 The Absorbable Cranial Flap Fixation System of MedArt won the iF Design Award 2019
2019/02 The general manager of MedArt was engaged as the specially-invited expert of Key Laboratory of Bone Implant Interface Function and Individuation Research Enterprises in Tianjin
2019/04 MedArt obtained the Certificates for Safety Production Standardization
2019/06 MedArt entered the Library of SEMs under Growth Project and Cultivation for the first time
2019/06 MedArt completed the construction of poly L-lactic acid material for surgical implantation production base and obtained the invention patent: A preparation method of poly L-lactic acid material for surgical implantation (ZL201710676933.6)
2019/08 The US invention patent for MedArt Absorbable Cranial Flap Fixation System was applied
2019/11 MedArt completed the construction of GelMA production base and obtained the invention patent: A preparation method of polyacrylate grafted modified gelatine-adhesive (ZL201710676932.1)
2018/01 MedArt joined the Sichuan Strategic Emerging Industry Promotion Agency and was awarded as the advanced enterprises in 2017
2018/03 MedArt entered the Library for National Science and Technology SMEs for the first time
2018/11 MedArt became one of the seed enterprises for Chengdu New Economic Gradient Cultivation Enterprises
2018/11 The Absorbable Cranial Flap Fixation System was listed in the Product Catalogue of Strategic Emerging Industries in Sichuan Province
2018/11 MedArt passed ISO13485:2016 Quality System Certification
2018/11 MedArt completed the A round financing
2017/06 The general manager of MedArt was selected for the "Rongpiao Plan" of high-level innovation and entrepreneurship talents plan, and was awarded the title of special expert in Chengdu
2017/12 MedArt was awarded as the most potential entrepreneurial enterprises founded by overseas returnees in 2017
2016/04 MedArt obtained the registration certificate of "Disposable Sterile Dressing" and the medical devices production license
2016/05 MedArt passed ISO13485:2003 Quality System Certification, and some products passed CE certification
2016/09 MedArt won the "Most Valuable Investment Award" of 2016 Nobel Laureates Medical Summit Innovation and Entrepreneurship Competition
2016/11 MedArt was awarded as "National High-tech Enterprise" for the first time
2016/12 The poly L-lactic acid for implantation with high optical purity prepared by the company was verified by the authoritative certifying organization to meet requirements of YY/T0661
2016/12 MedArt obtained the Qualified Registration Test Report of Absorbable Cranial Flap Fixation System (Report No. 2016-GJ-0647)
2015/01 MedArt obtained the registration certificate of "Medical Disinfectant Ultrasonic Couplant" and the medical devices production license
2015/09 MedArt completed the design and technical development of Absorbable Cranial Flap Fixation System
2015/10 MedArt completed the Pre-A round financing
2014/12 MedArt has completed the construction of R&D and production bases for biomedical materials and implant devices
2013/03 MedArt was founded